Authors:
Talley, NJ
Lauritsen, K
Tunturi-Hihnala, H
Lind, T
Moum, B
Bang, C
Schulz, T
Omland, TM
Delle, M
Junghard, O
Citation: Nj. Talley et al., Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6months, ALIM PHARM, 15(3), 2001, pp. 347-354
Citation: Sj. Edwards et al., Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis, ALIM PHARM, 15(11), 2001, pp. 1729-1736
Citation: Lb. Ilkjaer et T. Lind, Passengers' injuries reflected carriage interior at the railway accident in Mundelstrup, Denmark, ACC ANAL PR, 33(2), 2001, pp. 285-288
Authors:
Senay, C
Lind, T
Muguruma, K
Tone, Y
Kitagawa, H
Sugahara, K
Lidholt, K
Lindahl, U
Kusche-Gullberg, M
Citation: C. Senay et al., The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis, EMBO REP, 1(3), 2000, pp. 282-286
Citation: T. Lind, Changing surgical principles for castro-oesophageal reflux disease - is laparoscopic fundoplication justified in the light of surgical complications?, EURO J SURG, 165, 2000, pp. 31-33
Authors:
Bardhan, KD
Bayerdorffer, E
Van Zanten, SJOV
Lind, T
Megraud, F
Delchier, JC
Hellblom, M
Stubberod, A
Burman, CF
Gromark, PO
Zeijlon, L
Citation: Kd. Bardhan et al., The HOMER study: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection, HELICOBACT, 5(4), 2000, pp. 196-201
Authors:
Liu, JZ
Li, XM
Drost, J
Thorland, EC
Liu, Q
Lind, T
Roberts, S
Wang, HY
Sommer, SS
Citation: Jz. Liu et al., The human factor IX gene as germline mutagen test: Samples from mainland China have the putatively endogenous pattern of mutation, HUM MUTAT, 16(1), 2000, pp. 31-36
Authors:
Lind, T
Rydberg, L
Kyleback, A
Jonsson, A
Andersson, T
Hasselgren, G
Holmberg, J
Rohss, K
Citation: T. Lind et al., Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease, ALIM PHARM, 14(7), 2000, pp. 861-867
Authors:
Van Zanten, SV
Lauritsen, K
Delchier, J
Labenz, J
De Argila, CM
Lind, T
Treichel, HC
Stubberod, A
Cockeram, A
Hasselgren, G
Gothe, L
Wrangstadh, M
Sinclair, P
Citation: Sv. Van Zanten et al., One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease, ALIM PHARM, 14(12), 2000, pp. 1605-1611
Authors:
Hodson, N
Griffiths, G
Cook, N
Pourhossein, M
Gottfridson, E
Lind, T
Lidholt, K
Roberts, IS
Citation: N. Hodson et al., Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha-UDP-GlcNAc glycosyltransferase - The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC, J BIOL CHEM, 275(35), 2000, pp. 27311-27315
Authors:
Bayerdorffer, E
Lind, T
Dite, P
Bardhan, KD
O'Morain, C
Delchier, JC
Spiller, R
van Zanten, SV
Sipponen, P
Megraud, F
Zeijlon, L
Citation: E. Bayerdorffer et al., Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection, EUR J GASTR, 11, 1999, pp. S19-S22
Authors:
Lind, T
Havelund, T
Lundell, L
Glise, H
Lauritsen, K
Pedersen, SA
Anker-Hansen, O
Stubberod, A
Eriksson, G
Carlsson, R
Junghard, O
Citation: T. Lind et al., On demand therapy with omeprazole for the long-term management of patientswith heartburn without oesophagitis - a placebo-controlled randomized trial, ALIM PHARM, 13(7), 1999, pp. 907-914
Authors:
Malfertheiner, P
Bayerdorffer, E
Diete, U
Gil, J
Lind, T
Misiuna, P
O'Morain, C
Sipponen, P
Spiller, RC
Stasiewicz, J
Treichel, HC
Ujszaszy, L
Unge, P
Van Zanten, SJOV
Zeijlon, L
Citation: P. Malfertheiner et al., The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer, ALIM PHARM, 13(6), 1999, pp. 703-712
Authors:
Van Zanten, SJOV
Bradette, M
Farley, A
Leddin, D
Lind, T
Unge, P
Bayerdorffer, E
Spiller, RC
O'Morain, C
Sipponen, P
Wrangstadh, M
Zeijlon, L
Sinclair, P
Citation: Sjov. Van Zanten et al., The DU-MACH study: eradication of Helicobacter pylori and ulcer healing inpatients with acute duodenal ulcer using omeprazole based triple therapy, ALIM PHARM, 13(3), 1999, pp. 289-295
Authors:
Maenhaut, W
Fernandez-Jimenez, MT
Lind, T
Kauppinen, EI
Valmari, T
Sfiris, G
Nilsson, K
Citation: W. Maenhaut et al., In-stack particle size and composition transformations during circulating fluidized bed combustion of willow and forest residue, NUCL INST B, 150(1-4), 1999, pp. 417-421
Authors:
Megraud, F
Lehn, N
Lind, T
Bayerdorffer, E
O'Morain, C
Spiller, R
Unge, P
Van Zanten, SV
Wrangstadh, M
Burman, CF
Citation: F. Megraud et al., Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study, ANTIM AG CH, 43(11), 1999, pp. 2747-2752
Authors:
Lind, T
Megraud, F
Unge, P
Bayerdorffer, E
O'Morain, C
Spiller, R
van Zanten, SV
Bardhan, KD
Hellblom, M
Wrangstadh, M
Zeijlon, L
Cederberg, C
Citation: T. Lind et al., The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies, GASTROENTY, 116(2), 1999, pp. 248-253
Authors:
Tsuchida, K
Lind, T
Kitagawa, H
Lindahl, U
Sugahara, K
Lidholt, K
Citation: K. Tsuchida et al., Purification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesis, EUR J BIOCH, 264(2), 1999, pp. 461-467
Authors:
Lind, T
Valmari, T
Kauppinen, EI
Sfiris, G
Nilsson, K
Maenhaut, W
Citation: T. Lind et al., Volatilization of the heavy metals during circulating fluidized bed combustion of forest residue, ENV SCI TEC, 33(3), 1999, pp. 496-502
Authors:
Havelund, T
Lind, T
Wiklund, I
Glise, H
Hernqvist, H
Lauritsen, K
Lundell, L
Pedersen, SA
Carlsson, R
Junghard, O
Stubberod, A
Anker-Hansen, O
Citation: T. Havelund et al., Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole, AM J GASTRO, 94(7), 1999, pp. 1782-1789